A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment

Iodine-131 meta-iodobenzylguanidine ((131)I-mIBG) has been utilized as a standard treatment to minimize adverse side effects by targeting therapies to bind to the norepinephrine transporter (NET) expressed on 90% of neuroblastoma cells. However, only a minority of patients who receive (131)I-mIBG ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Saimuang, Kween, Suttisintong, Khomson, Kaewchangwat, Narongpol, Thanayupong, Eknarin, Wongngam, Yodsathorn, Charoenphun, Putthiporn, Wanotayan, Rujira, Elaissari, Abdelhamid, Hongeng, Suradej, Polpanich, Duangporn, Jangpatarapongsa, Kulachart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037022/
https://www.ncbi.nlm.nih.gov/pubmed/35478920
http://dx.doi.org/10.1039/d1ra04054e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037022/
https://www.ncbi.nlm.nih.gov/pubmed/35478920
http://dx.doi.org/10.1039/d1ra04054e

Ejemplares similares